Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hyuk-Chan Kwon

Showing results (71-80 of 124) with videos related to

Pageof 13
Sort By:
Diseases of the Colon and Rectum|March 27, 2004
Gene expression profiling in lymph node-positive and lymph node-negative colorectal cancerHyuk-Chan Kwon, Sung-Hyun Kim, Mee-Sook Roh, et al.
Investigational New Drugs|March 19, 2010
Phase II study of irinotecan/S-1 combination chemotherapy for patients with oxaliplatin-refractory colorectal cancerSung Yong Oh, Young-Tae Ju, Sang-Kyung Choi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2009
In vitro and in vivo radiosensitization of glioblastoma cells by the poly (ADP-ribose) polymerase inhibitor E7016Andrea L Russo, Hyuk-Chan Kwon, William E Burgan, et al.
Cardiovascular and Interventional Radiology|June 18, 2009
Radiofrequency ablation of renal VX2 tumors with and without renal artery occlusion in a rabbit model: feasibility, therapeutic efficacy, and safetySeong Kuk Yoon, Jong Cheol Choi, Jin Han Cho, et al.
Investigational New Drugs|February 4, 2012
A phase II trial of Erlotinib in combination with gemcitabine and cisplatin in advanced pancreatic cancerIn Gyu Hwang, Joung-Soon Jang, Sung Yong Oh, et al.
Carbohydrate Polymers|January 2, 2022
Injectable glycol chitosan thermogel formulation for efficient inner ear drug deliveryYang Yu, Da Hae Kim, Eun Yeong Suh, et al.
World Journal of Gastroenterology|February 21, 2006
Pilot study of postoperative adjuvant chemoradiation for advanced gastric cancer: adjuvant 5-FU/cisplatin and chemoradiation with capecitabineHyung-Sik Lee, Youngmin Choi, Won-Joo Hur, et al.
American Journal of Clinical Oncology|April 14, 2009
Second-line treatment with a combination of continuous 5-fluorouracil, doxorubicin, and mitomycin-C (conti-FAM) in gemcitabine-pretreated pancreatic and biliary tract cancerSuee Lee, Sung Yong Oh, Byung Geun Kim, et al.
Cancer Research and Treatment|August 19, 2009
Phase II study of gemcitabine plus cisplatin in patients with anthracycline- and taxane- pretreated metastatic breast cancerJung Hwan Kim, Sung Yong Oh, Hyuk-Chan Kwon, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|December 8, 2010
Clinicopathologic significance of ERCC1, thymidylate synthase and glutathione S-transferase P1 expression for advanced gastric cancer patients receiving adjuvant 5-FU and cisplatin chemotherapyKi Han Kim, Hyuk-Chan Kwon, Sung Yong Oh, et al.
Pageof 13

Showing results (71-80 of 124) with videos related to

Sort By:
Pageof 13
Diseases of the Colon and Rectum|March 27, 2004
Gene expression profiling in lymph node-positive and lymph node-negative colorectal cancerHyuk-Chan Kwon, Sung-Hyun Kim, Mee-Sook Roh, et al.
Investigational New Drugs|March 19, 2010
Phase II study of irinotecan/S-1 combination chemotherapy for patients with oxaliplatin-refractory colorectal cancerSung Yong Oh, Young-Tae Ju, Sang-Kyung Choi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2009
In vitro and in vivo radiosensitization of glioblastoma cells by the poly (ADP-ribose) polymerase inhibitor E7016Andrea L Russo, Hyuk-Chan Kwon, William E Burgan, et al.
Cardiovascular and Interventional Radiology|June 18, 2009
Radiofrequency ablation of renal VX2 tumors with and without renal artery occlusion in a rabbit model: feasibility, therapeutic efficacy, and safetySeong Kuk Yoon, Jong Cheol Choi, Jin Han Cho, et al.
Investigational New Drugs|February 4, 2012
A phase II trial of Erlotinib in combination with gemcitabine and cisplatin in advanced pancreatic cancerIn Gyu Hwang, Joung-Soon Jang, Sung Yong Oh, et al.
Carbohydrate Polymers|January 2, 2022
Injectable glycol chitosan thermogel formulation for efficient inner ear drug deliveryYang Yu, Da Hae Kim, Eun Yeong Suh, et al.
World Journal of Gastroenterology|February 21, 2006
Pilot study of postoperative adjuvant chemoradiation for advanced gastric cancer: adjuvant 5-FU/cisplatin and chemoradiation with capecitabineHyung-Sik Lee, Youngmin Choi, Won-Joo Hur, et al.
American Journal of Clinical Oncology|April 14, 2009
Second-line treatment with a combination of continuous 5-fluorouracil, doxorubicin, and mitomycin-C (conti-FAM) in gemcitabine-pretreated pancreatic and biliary tract cancerSuee Lee, Sung Yong Oh, Byung Geun Kim, et al.
Cancer Research and Treatment|August 19, 2009
Phase II study of gemcitabine plus cisplatin in patients with anthracycline- and taxane- pretreated metastatic breast cancerJung Hwan Kim, Sung Yong Oh, Hyuk-Chan Kwon, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|December 8, 2010
Clinicopathologic significance of ERCC1, thymidylate synthase and glutathione S-transferase P1 expression for advanced gastric cancer patients receiving adjuvant 5-FU and cisplatin chemotherapyKi Han Kim, Hyuk-Chan Kwon, Sung Yong Oh, et al.
Pageof 13